Press release
Biological Drugs Market to Reach US$ 287,139.7 Mn by 2030
Biological Drugs Market 2022-2030
The Global Biological Drugs Market is slated to grow on a stellar note going forward. The current situation is that digitization, which has the capacity of changing the dynamics of any vertical, has made a beeline to the healthcare vertical. The world out there no more depends on references for choosing healthcare services but goes for 360-degree research before arriving at the final decision. This would be the digitized healthcare vertical in the future.
According to a new market report published by Persistence Market Research "Global Market Study on Biological Drugs: North America to Witness Highest Growth By 2030", the global biological drugs market was valued at US$ 161,056.5 Mn in 2021 and is expected to grow at a CAGR of 10.1% from 2021 to 2020, to reach US$ 287,139.7 Mn by 2030.
Get Free Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/2883
Biological drugs are typically derived from living cells and are used in the prevention and treatment of various diseases such as cancer, blood disorders, auto-immune diseases, and other medical disorders. Biological drugs have more complex structures compared to that of conventional drugs.
Some of the major players in the biological drugs market:
Pfizer Inc.
Abbott Laboratories.
Novartis AG.
Eli Lilly and Company.
GlaxoSmithKline plc.
Bristol-Myers Squibb Company.
Merck & Co., Inc.
Amgen Inc.
Baxter International Inc.
Biogen Idec.
Other
Request for Methodology@ https://www.persistencemarketresearch.com/methodology/2883
Globally, the biological drugs market is witnessing significant growth due to the increasing prevalence of chronic diseases and growing geriatric population. In addition, health and awareness initiatives by various government associations are also supporting the growth of the biological drugs market. However, high costs of biological drugs and patent expiry of blockbuster drugs impede the growth of the biological drugs market. Moreover, risks of adverse effects associated with biologic injectable drugs also inhibit the growth of the market.
North America dominates the global biological drugs market. This is due to increasing use of biological drugs in the treatment of diseases such as cancer, diabetes, and other chronic diseases in the region. In addition, several clinics in the region are focusing on biological drugs for the treatment of various diseases.
The biological drugs market in Europe is growing due to increasing aging population in the region. For instance, according to a UN report, elderly people accounted for 23.2% of the total population in Germany in 2000, and the number is expected to reach 33.2% by 2025. Aging can lead to certain disorders such as age-related macular degeneration and glaucoma, which require effective biological drugs for their treatment.
Low manufacturing costs in Asia are attracting biopharmaceutical companies to invest in the region, supporting the growth of the biological drugs market. Moreover, governments of some Asian countries are also supporting the growth of the biological drugs market by providing funds to life sciences research institutes and biotech companies for the construction of R&D and manufacturing facilities..
The global biological drugs market is segmented as follows:
By therapeutic protein
Enbrel
Lantus
Neulasta
Avonex
NovoLog
Rebif
Humalog
Aranesp
Epogen
Levemir
Victoza
Betaseron
Neupogen
Eylea
By monoclonal antibody (mAb)
Humira
Remicade
Rituxan
Avastin
Herceptin
Lucentis
By vaccine
Take 13
Gardasil
Fluzone
Varivax
Cervarix
By geography
North America
Europe
Asia
Rest of the World (RoW)
Access Full Report@ https://www.persistencemarketresearch.com/checkout/2883
Key Questions Answered in the Biological Drugs Market Report
How is the Biological Drugs market expected to grow over the projected period?
What direction is the Biological Drugs market expected to take in terms of volume and value during the forecast period?
What is the impact of macroeconomic factors on the Biological Drugs market in future?
What are the key market drivers in the Biological Drugs market?
What are significant opportunities and improvement areas for Biological Drugs manufacturers?
What are the key developments and trends taking over the Biological Drugs market?
Which are the emerging countries that are expected to create significant growth opportunities in the Biological Drugs market?
Contact us:
Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com
About us:
PersistenceMarketResearch is an esteemed company with a reputation of serving clients across domains of information technology (IT), healthcare, and chemicals. Our analysts undertake painstaking primary and secondary research to provide a seamless report with a 360 degree perspective. Data is compared against rep/uted organizations, trustworthy databases, and international surveys for producing impeccable reports backed with graphical and statistical information.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Biological Drugs Market to Reach US$ 287,139.7 Mn by 2030 here
News-ID: 2591388 • Views: …
More Releases from Persistence Market Research
Europe Textile Recycling Market to Reach US$ 2,966.5 Mn by 2032: Growth Driven b …
The Europe textile recycling market is undergoing a remarkable transformation as the region embraces sustainability, circular economy practices, and eco-conscious consumer behavior. Textile recycling-once a niche concept-has now become an integral part of Europe's strategy to reduce waste, conserve resources, and promote ethical fashion. Driven by government initiatives, growing awareness of textile waste's environmental impact, and technological innovation, the market is poised for steady growth in the coming years.
According to…
Agricultural Microbial Market to Reach US$ 17.47 Bn by 2032: Growth Driven by Su …
The agricultural microbial market is gaining remarkable traction as global farming practices shift toward sustainability, efficiency, and soil health improvement. Microbials-comprising beneficial bacteria, fungi, viruses, and protozoa-play a vital role in promoting plant growth, enhancing nutrient uptake, and protecting crops from diseases. With the world facing mounting pressure to increase agricultural productivity while minimizing environmental impact, microbial-based products are emerging as essential tools for modern agriculture.
According to the latest study…
Pine-derived Chemicals Market to Reach US$ 8.7 Bn by 2032, Driven by Rising Dema …
The global pine-derived chemicals market is witnessing steady growth as industries increasingly shift toward bio-based, renewable, and sustainable raw materials. Derived from pine trees, these chemicals-such as rosin, turpentine, and tall oil-are used in a variety of industrial and consumer applications, ranging from adhesives and coatings to food, pharmaceuticals, and personal care products. With growing awareness about environmental sustainability and the circular economy, pine-derived chemicals are gaining prominence as natural…
Bio-succinic Acid Market to Reach US$ 415.3 Mn by 2032: Growth Driven by Rising …
The bio-succinic acid market is rapidly emerging as a key component of the global bio-based chemical industry, owing to its versatile applications and sustainable production process. Bio-succinic acid, derived from renewable feedstocks such as sugar, corn, and agricultural waste, serves as a sustainable alternative to petrochemical-based succinic acid. Its eco-friendly nature, combined with rising concerns over carbon emissions and fossil fuel depletion, has made it increasingly popular across multiple industries.
According…
More Releases for Biological
Biological Control Market Projected to Witness Massive Growth - Koppert Biologic …
Biological Control Market Snapshot
The Biological Control Market is projected to reach USD 9.7 billion by 2032, growing at a CAGR of 9.4% from 2025 to 2032.
Coherent Market Insights proudly presents its latest Biological Control Market Research Report, delivering a detailed examination of the U.S. Biological Control Market outlook from 2025 to 2032. This comprehensive analysis provides strategic forecasts at both national and regional levels, addressing evolving supply networks, payer-provider collaboration,…
Biological and Chemical Indicators Market - Beyond Measure: Biological and Chemi …
Newark, New Castle, USA: The "Biological and Chemical Indicators Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Biological and Chemical Indicators Market: https://www.growthplusreports.com/report/biological-and-chemical-indicators-market/8887
This latest report researches the…
Biological APIs Market - Biological APIs: The Driving Force Behind Cutting-Edge …
Newark, New Castle, USA: The "Biological APIs Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Biological APIs Market: https://www.growthplusreports.com/report/biological-apis-market/8769
This latest report researches the industry structure, sales, revenue,…
Human Immunoglobulin for Intravenous Injection Market demand and future scope wi …
A recent market research report added to repository of MR Accuracy Reports is an in-depth analysis of global Human Immunoglobulin for Intravenous Injection. On the basis of historic growth analysis and current scenario of Human Immunoglobulin for Intravenous Injection place, the report intends to offer actionable insights on global market growth projections. Authenticated data presented in report is based on findings of extensive primary and secondary research. Insights drawn from…
Global Biological safety testing Market | Global Biological safety testing Indus …
Biologics are termed as those product that attained from living organism and feature a differentiate set of properties. The biologics want extreme safety from contamination thus biological safety testing is incorporate timely to make sure its safety quality and non-contamination of vaccines & biopharmaceuticals, along with comply with the bound rules applicable on it. A number of the foremost biological tests are sterility testing, bioburden testing, residual host contaminant detection…
Meningococcal Infections Vaccine Market Insights, Forecast to 2025 : Sanofi-Past …
Researchmoz added Most up-to-date research on "Global Meningococcal Infections Vaccine Market Insights, Forecast to 2025" to its huge collection of research reports.
This report studies the global market size of Meningococcal Infections Vaccine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Meningococcal Infections Vaccine in these regions.
This research report categorizes the global Meningococcal Infections Vaccine market…
